Acute Exacerbation Of Copd clinical trials

Explore recruiting acute exacerbation of copd clinical trials.

Recruiting acute exacerbation of copd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Exacerbation Of Copd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized, double-blind, placebo-controlled, parallel-group Phase 3 study to evaluate the efficacy, safety, and tolerability of SAR440340/REGN3500/itepekimab (anti-IL-33 mAb) in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Czechia, Germany, Poland, Hungary, Spain, France +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, double-blind, placebo-controlled, parallel-group Phase 3 study to evaluate the efficacy, safety, and tolerability of SAR440340/REGN3500/itepekimab (anti-IL-33 mAb) in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) (AERIFY-1)

Romania, Slovakia, Bulgaria, Italy, Czechia, Poland +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A double-blinded extension study to evaluate the long-term safety and tolerability of itepekimab in patients with chronic obstructive pulmonary disease (COPD) who participated in either EFC16750 or EFC16819 clinical studies

Denmark, Latvia, Portugal, Poland, Germany, Romania +12 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Acute Exacerbation Of Copd trials by city

Acute Exacerbation Of Copd in Toronto Acute Exacerbation Of Copd in Vancouver Acute Exacerbation Of Copd in Montreal Acute Exacerbation Of Copd in Calgary Acute Exacerbation Of Copd in Edmonton Acute Exacerbation Of Copd in Ottawa Acute Exacerbation Of Copd in Winnipeg Acute Exacerbation Of Copd in Quebec City Acute Exacerbation Of Copd in Hamilton Acute Exacerbation Of Copd in Kitchener Acute Exacerbation Of Copd in London Acute Exacerbation Of Copd in Halifax Acute Exacerbation Of Copd in New York Acute Exacerbation Of Copd in Los Angeles Acute Exacerbation Of Copd in Chicago Acute Exacerbation Of Copd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease